ICU Medical logo.jpg
ICU Medical, Inc. Announces Third Quarter 2021 Results
November 03, 2021 16:05 ET | ICU Medical, Inc.
SAN CLEMENTE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and...
Clover_Logo_Green_RGB.jpg
Clover Health to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference on November 10, 2021
November 03, 2021 16:05 ET | Clover Health Investments, Corp.
NASHVILLE, Tenn., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a technology company committed to improving health equity for America's underserved seniors, today announced that...
OraSure Technologies, Inc. Logo
OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22
November 03, 2021 16:05 ET | OraSure Technologies, Inc.
Third quarter revenue of $53.9 million grew 12% year-over-year; excluding COVID-19 product revenues, revenues for the quarter grew 37% from the prior year, demonstrating strong growthOraSure signs...
CBAY Logo.jpg
CymaBay Therapeutics to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
November 03, 2021 16:05 ET | CymaBay Therapeutics, Inc.
NEWARK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic...
Neubase_Logo_RGB_Black.png
NeuBase to Present at the Jefferies London Healthcare Conference
November 03, 2021 16:05 ET | NeuBase Therapeutics, Inc.
PITTSBURGH, Nov. 03, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company Drugging the Genome™ to address disease at the...
RevolutionLogo.png
Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021
November 03, 2021 16:05 ET | Revolution Medicines, Inc.
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
TEKNOVA Logo Pur_RGB copy 2.png
Teknova to Report Third Quarter 2021 Financial Results on November 10, 2021
November 03, 2021 16:05 ET | Alpha Teknova, Inc.
HOLLISTER, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical...
exponent.jpg
Exponent to Present at Upcoming Investor Conference
November 03, 2021 16:05 ET | Exponent, Inc.
MENLO PARK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker,...
Altair_Brandmark_Hz_RGB_FullColor.jpg
Altair To Virtually Present at the RBC Global Technology, Internet, Media and Telecom Conference
November 03, 2021 16:05 ET | Altair Engineering Inc.
TROY, Mich., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Altair (Nasdaq: ALTR), the global leader converging simulation, HPC, and AI, today announced that James Scapa, chairman and chief executive officer,...
NewInfineraLogo.jpg
Infinera Corporation Reports Third Quarter 2021 Financial Results
November 03, 2021 16:03 ET | Infinera Corporation
SAN JOSE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) today released financial results for its third quarter ended September 25, 2021. GAAP revenue for the...